SCHEMBL30708167

SCHEMBL30708167

Cc1cn2cc(-c3cc4ccc(N5CCN[C@@H](C)C5)cc4oc3=O)nc2c(C)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.41
ALDH1A1 P00352 4/20 0.41
RAB9A P51151 4/20 0.41
KDM4E B2RXH2 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KHK P50053 1/20 0.38
MAPT P10636 4/20 0.37
POLB P06746 1/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
ALK Q9UM73 1/20 0.36
LMNA P02545 1/20 0.35
PKM P14618 1/20 0.35
USP25 Q9UHP3 3/20 0.34
USP28 Q96RU2 2/20 0.34
TP53 P04637 5/20 0.33
MAOB P27338 3/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15065774 1.00 NPC1 (0.41) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL15066190 1.00 NPC1 (0.41) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL16669609 1.00 NPC1 (0.41) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL15069239 0.91 NPC1 (0.39) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL15069023 0.91 NPC1 (0.39) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL21301285 0.91 NPC1 (0.42) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL15086329 0.91 NPC1 (0.42) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL15069221 0.91 HTT (0.41) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL27261173 0.91 MAOB (0.39) NPC1ALDH1A1RAB9AKDM4EL3MBTL1
SCHEMBL15068754 0.90 HTT (0.41) NPC1ALDH1A1RAB9AKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024006287-A2 ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 UNIVERSITY OF KANSAS (US) 2024-01-04 WO claimed
WO-2024006287-A2 ANTIVIRAL COMPOUNDS USEFUL AGAINST SARS-COV-2 UNIVERSITY OF KANSAS (US) 2024-01-04 WO disclosed